Cyramza (Ramucirumab) Dosing
Generic name : Ramucirumab.
Trade name : Cyramza.
Manufacturer information :
Cyramza is manufactured by Eli Lilly and Company.
Cyramza FDA Approval :
Cyramza First approved April 21st, 2014.
Dosage form :
- 100 mg/10 mL (10 mg per mL) solution, single-dose vial.
- 500 mg/50 mL (10 mg per mL) solution, single-dose vial.
Cyramza Indications and Usage :
- Gastric Cancer.
- Non-Small Cell Lung Cancer.
- Colorectal Cancer.
Cyramza (Ramucirumab) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.